Literature DB >> 22426020

Changes in glycemic control are associated with changes in cognition in non-diabetic elderly.

Ramit Ravona-Springer1, Erin Moshier, James Schmeidler, James Godbold, Jimmy Akrivos, Michael Rapp, Hillel T Grossman, Michael Wysocki, Jeremy M Silverman, Vahram Haroutunian, Michal Schnaider Beeri.   

Abstract

The aim of the present study was to examine the relationship of changes in long term glucose levels as measured by Hemoglobin A1c (HbA1c) with simultaneous changes in cognition. The sample included in the present analysis consisted of 101 community dwelling non-diabetic elderly subjects participating in ongoing longitudinal studies of cognition. Subjects were included in this study if they were cognitively normal at baseline, had at least one co-temporaneous follow-up assessment of HbA1c and the Mini Mental State Exam (MMSE), and complete data on age, gender, race, and years of education. MMSE decline over time was the main outcome measure. In TOBIT mixed regression models, MMSE was the dependent variable and HbA1c the time-varying covariate. Sociodemographic (age, gender, and education), cardiovascular (hypertension and APOE4 status), and lifestyle (smoking and physical activity) covariates were included in the statistical model. After adjusting for age at follow-up, there was a decrease of 1.37 points in the MMSE (p = 0.0002) per unit increase in HbA1c. This result remained essentially unchanged after adjusting also for gender and education (p = 0.0005), cardiovascular factors (p = 0.0003), and lifestyle (p = 0.0006). Additionally, results remained very similar after excluding subjects with potentially incipient diabetes with HbA1c between 6 and 7. These findings suggest that in non-diabetic non-demented elderly subjects, an increase in HbA1c over time is associated with cognitive decline. Such results may have broad clinical applicability since manipulation of glucose control, even in non-diabetics, may affect cognitive performance, perhaps enabling preventive measures against dementia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426020      PMCID: PMC3586408          DOI: 10.3233/JAD-2012-120106

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  44 in total

1.  Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination.

Authors:  A Hensel; M C Angermeyer; S G Riedel-Heller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-18       Impact factor: 10.154

2.  Association of duration and severity of diabetes mellitus with mild cognitive impairment.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Teresa J H Christianson; V Shane Pankratz; Bradley F Boeve; Adrian Vella; Walter A Rocca; Ronald C Petersen
Journal:  Arch Neurol       Date:  2008-08

Review 3.  Aging of the brain, entropy, and Alzheimer disease.

Authors:  David A Drachman
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

4.  Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.

Authors:  M S Beeri; J Schmeidler; M Sano; J Wang; R Lally; H Grossman; J M Silverman
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

5.  Diabetes mellitus in midlife and the risk of dementia three decades later.

Authors:  M Schnaider Beeri; U Goldbourt; J M Silverman; S Noy; J Schmeidler; R Ravona-Springer; A Sverdlick; M Davidson
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

6.  Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology.

Authors:  M S Beeri; J Schmeidler; J M Silverman; S Gandy; M Wysocki; C M Hannigan; D P Purohit; G Lesser; H T Grossman; V Haroutunian
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

7.  Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment.

Authors:  Robert S Wilson; Julie A Schneider; Steven E Arnold; Julia L Bienias; David A Bennett
Journal:  Arch Gen Psychiatry       Date:  2007-10

8.  Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.

Authors:  C Enzinger; F Fazekas; P M Matthews; S Ropele; H Schmidt; S Smith; R Schmidt
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

9.  Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004.

Authors:  Lydie N Pani; Leslie Korenda; James B Meigs; Cynthia Driver; Shadi Chamany; Caroline S Fox; Lisa Sullivan; Ralph B D'Agostino; David M Nathan
Journal:  Diabetes Care       Date:  2008-07-15       Impact factor: 17.152

10.  Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study.

Authors:  Weili Xu; Chengxuan Qiu; Margaret Gatz; Nancy L Pedersen; Boo Johansson; Laura Fratiglioni
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

View more
  28 in total

1.  The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics.

Authors:  Michal Schnaider Beeri; Ramit Ravona-Springer; Erin Moshier; James Schmeidler; James Godbold; Tomas Karpati; Derek Leroith; Keren Koifman; Efrat Kravitz; Rachel Price; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

Review 2.  Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

Authors:  Efrat Kravitz; James Schmeidler; Michal Schnaider Beeri
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

3.  The chicken or the egg? Does glycaemic control predict cognitive function or the other way around?

Authors:  Ithamar Ganmore; Michal Schnaider Beeri
Journal:  Diabetologia       Date:  2018-07-12       Impact factor: 10.122

Review 4.  The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.

Authors:  Michael L Alosco; John Gunstad
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

Review 5.  Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

Authors:  Subbiah Pugazhenthi; Limei Qin; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-05-06       Impact factor: 5.187

6.  Haptoglobin genotype modulates the relationships of glycaemic control with cognitive function in elderly individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Andrew Levy; Derek Leroith; Michal S Beeri
Journal:  Diabetologia       Date:  2015-01-28       Impact factor: 10.122

Review 7.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

8.  Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes.

Authors:  Abigail Livny; Ramit Ravona-Springer; Anthony Heymann; Rachel Priess; Tammar Kushnir; Galia Tsarfaty; Leeron Rabinov; Reut Moran; Hadass Hoffman; Itzik Cooper; Lior Greenbaum; Jeremy Silverman; Mary Sano; Sterling C Johnson; Barbara B Bendlin; Michal Schnaider Beeri
Journal:  Diabetes Care       Date:  2016-04-08       Impact factor: 19.112

9.  Dietary glycaemic load associated with cognitive performance in elderly subjects.

Authors:  Susan E Power; Eibhlís M O'Connor; R Paul Ross; Catherine Stanton; Paul W O'Toole; Gerald F Fitzgerald; Ian B Jeffery
Journal:  Eur J Nutr       Date:  2014-07-18       Impact factor: 5.614

Review 10.  Is Alzheimer's disease a systemic disease?

Authors:  Jill K Morris; Robyn A Honea; Eric D Vidoni; Russell H Swerdlow; Jeffrey M Burns
Journal:  Biochim Biophys Acta       Date:  2014-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.